Clinical Trials

AI-Driven MS Neuroimaging – Review
Tech & Innovation AI-Driven MS Neuroimaging – Review

For more than a century, neurologists have known that the cognitive decay associated with multiple sclerosis stems from damage to the brain’s gray matter, yet these vital areas remained stubbornly invisible on conventional MRI scans until the arrival of sophisticated computational models. The

New Gene Therapy Targets Brain via the Glymphatic System
Research & Development New Gene Therapy Targets Brain via the Glymphatic System

The persistent challenge of delivering life-saving genetic material across the nearly impenetrable blood-brain barrier has long remained the single greatest hurdle in the field of modern neurology and neurosurgery. A sophisticated gene therapy platform, recently detailed in the journal Nature

Can Yogurt and Probiotics Lower Colorectal Cancer Risk?
Research & Development Can Yogurt and Probiotics Lower Colorectal Cancer Risk?

The intricate landscape of the human digestive tract operates as a sprawling internal metropolis where trillions of microscopic inhabitants influence everything from metabolic efficiency to the risk of developing life-threatening diseases. Colorectal cancer continues to persist as a major global

CMS Integrates Digital Health Tools to Modernize Medicare
Tech & Innovation CMS Integrates Digital Health Tools to Modernize Medicare

The ongoing transformation of federal healthcare services has reached a pivotal moment as the gap between consumer technology and public health administration finally begins to narrow significantly for millions of older Americans. This demographic shift, characterized by a generation of seniors who

Stoke Completes Phase 3 Enrollment for Dravet Drug Zorevunersen
Management & Regulatory Stoke Completes Phase 3 Enrollment for Dravet Drug Zorevunersen

The landscape of genetic medicine is shifting rapidly as researchers move beyond merely managing the symptoms of chronic conditions to addressing the very foundations of biological dysfunction within the human body. Dravet syndrome represents one of the most challenging forms of epilepsy,

UCLA Advances CAR-NKT Cell Therapy for Multiple Sclerosis
Research & Development UCLA Advances CAR-NKT Cell Therapy for Multiple Sclerosis

The traditional approach to managing chronic autoimmune conditions has long relied on suppressing the entire immune system, but a transformative breakthrough from researchers at UCLA is now steering the medical community toward a more precise, cell-based future. By securing a substantial seven

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later